Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos - Psychedelic Alpha
Last Thursday, FDA published the complete response letter (CRL) it sent to Lykos Therapeutics last year, when it rejected its MDMA for PTSD new drug application. Here, we take a closer look at the…| Psychedelic Alpha
